Risperdal gynecomastia is a condition that has allegedly affected many men and boys who were treated with the atypical antipsychotic drug, Risperdal. Marked by the development of excessive male breast tissue, Risperdal male breast growth is more than an embarrassing problem. The condition can be painful, and often requires victims to undergo extensive surgical procedures, including liposuction and mastectomy, to remove excess breast tissue.
Dozens of lawsuits are now making their way through courts around the country that seek compensation for alleged victims of Risperdal breast growth. If you or someone you care about developed gynecomastia from Risperdal, the attorneys at Bernstein Liebhard LLP can take a look at your case and help you determine if you also have a valid claim for compensation. This litigation is moving quickly, so don’t wait. Contact our office today for your free, no obligation Risperdal gynecomastia lawsuit review.
Risperdal is an atypical antipsychotic used to treat psychiatric conditions, such as bipolar disorder and schizophrenia in adult and pediatric patients, as well as irritability in autistic children. The drug is also sometimes used off-label to treat ADHD in children. Its active ingredient in is risperidone.
It is thought that risperidone breast growth occurs because the drug stimulates the body to develop excessive levels of prolactin, a hormone that is tied to breast development and lactation in women. Studies have suggested a possible link between Risperdal and breast development since 1999, when research was published that indicated gynecomastia could occur in men treated with a combination Risperdal and Prozac. In 2006, a study published in the Journal of Clinical Psychopharmacology found that children who took Risperdal had abnormally high levels of prolactin. In 2009, a study appearing in the Journal of Child and Adolescent Psychopharmacology found that prolactin levels could remain elevated for two years once the drug was stopped.
Risperdal male breast development may be accompanied by the following signs and symptoms:
Risperdal gynecomastia is not reversible, even once a patient stops taking the medication, and surgical intervention is often required. This may involve liposuction to reduce excess tissue, and even mastectomy to completely remove the breasts.
Dozens of lawsuits filed on behalf of men and boys who allegedly developed Risperdal male breasts are now moving forward in courts around the country. All of these claims allege that Johnson & Johnson and its Janssen Pharmaceuticals unit hid the risk of Risperdal gynecomastia. They also claim that the companies improperly marketed Risperdal for use in children long before the drug was approved for pediatric indications.
Many of the Risperdal male breast lawsuits filed in recent years have been consolidated in a mass tort litigation underway in the Philadelphia Court of Common Pleas, Pennsylvania. In October 2012, it was reported that at least five lawsuits involving Risperdal breasts were settled in the proceeding for undisclosed amounts just before the cases were scheduled to go to trial.
Man and boys who suffered Risperdal gynecomastia may be entitled to compensation for the cost of their medical treatments, emotional distress and other damages. If you would like to learn more about the legal process involved in filing a claim, please contact Bernstein Liebhard LLP today by calling for your free case review.